MX9301546A - Preparado farmaceutico que contiene un canal activador de potasio y un receptor antagonista de la angiotensina ii y proceso para la fabricacion de tal preparado - Google Patents
Preparado farmaceutico que contiene un canal activador de potasio y un receptor antagonista de la angiotensina ii y proceso para la fabricacion de tal preparadoInfo
- Publication number
- MX9301546A MX9301546A MX9301546A MX9301546A MX9301546A MX 9301546 A MX9301546 A MX 9301546A MX 9301546 A MX9301546 A MX 9301546A MX 9301546 A MX9301546 A MX 9301546A MX 9301546 A MX9301546 A MX 9301546A
- Authority
- MX
- Mexico
- Prior art keywords
- receptor
- manufacture
- preparation
- pharmaceutical preparation
- preparation containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a un nuevo preparado farmacéutico conteniendo un canal activador de potasio ('KKA') y un receptor antagonista de la angiotensina II ('AR').
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4209071A DE4209071A1 (de) | 1992-03-20 | 1992-03-20 | Pharmazeutische zubereitung |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9301546A true MX9301546A (es) | 1993-09-01 |
Family
ID=6454609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9301546A MX9301546A (es) | 1992-03-20 | 1993-03-19 | Preparado farmaceutico que contiene un canal activador de potasio y un receptor antagonista de la angiotensina ii y proceso para la fabricacion de tal preparado |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0561357A1 (es) |
JP (1) | JPH0648961A (es) |
KR (1) | KR930019215A (es) |
CN (1) | CN1076357A (es) |
AU (1) | AU3528593A (es) |
CA (1) | CA2091942A1 (es) |
DE (1) | DE4209071A1 (es) |
HU (1) | HUT63764A (es) |
MX (1) | MX9301546A (es) |
NO (1) | NO931014L (es) |
PL (1) | PL298159A1 (es) |
TW (1) | TW237384B (es) |
ZA (1) | ZA931984B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5574049A (en) * | 1994-07-22 | 1996-11-12 | Sandoz Ltd. | 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3915236A1 (de) * | 1989-05-10 | 1990-11-15 | Merck Patent Gmbh | Pharmazeutische zubereitung |
DE4004268A1 (de) * | 1990-02-13 | 1991-08-14 | Merck Patent Gmbh | Pharmazeutische zubereitung |
-
1992
- 1992-03-20 DE DE4209071A patent/DE4209071A1/de not_active Withdrawn
-
1993
- 1993-03-01 CN CN93102019A patent/CN1076357A/zh active Pending
- 1993-03-16 EP EP19930104284 patent/EP0561357A1/de not_active Withdrawn
- 1993-03-16 AU AU35285/93A patent/AU3528593A/en not_active Abandoned
- 1993-03-17 KR KR1019930004054A patent/KR930019215A/ko not_active Application Discontinuation
- 1993-03-18 CA CA002091942A patent/CA2091942A1/en not_active Abandoned
- 1993-03-18 TW TW082101995A patent/TW237384B/zh active
- 1993-03-19 ZA ZA931984A patent/ZA931984B/xx unknown
- 1993-03-19 JP JP5098990A patent/JPH0648961A/ja active Pending
- 1993-03-19 HU HU9300796A patent/HUT63764A/hu unknown
- 1993-03-19 NO NO93931014A patent/NO931014L/no unknown
- 1993-03-19 MX MX9301546A patent/MX9301546A/es unknown
- 1993-03-19 PL PL29815993A patent/PL298159A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR930019215A (ko) | 1993-10-18 |
HUT63764A (en) | 1993-10-28 |
DE4209071A1 (de) | 1993-09-23 |
PL298159A1 (en) | 1993-10-18 |
CA2091942A1 (en) | 1993-09-21 |
JPH0648961A (ja) | 1994-02-22 |
HU9300796D0 (en) | 1993-06-28 |
CN1076357A (zh) | 1993-09-22 |
NO931014D0 (no) | 1993-03-19 |
EP0561357A1 (de) | 1993-09-22 |
AU3528593A (en) | 1993-09-23 |
NO931014L (no) | 1993-09-21 |
TW237384B (es) | 1995-01-01 |
ZA931984B (en) | 1993-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL111861A (en) | Phenyl-n-substituted azabicycloalkene derivatives and pharmaceutical compositions containing them | |
IL108520A0 (en) | Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them | |
TW239126B (es) | ||
EE03509B2 (et) | Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks | |
UA66750C2 (en) | Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors | |
LU91206I2 (fr) | Ceftiofur sous forme d'acide libre cristallin et ses dérivés pharmaceutiquement acceptables (naxcel) | |
EP0744942A4 (en) | HYDROGEL FORMULATION WITH CONTROLLED RELEASE | |
DE59609926D1 (de) | Stabilisierte schilddrüsenhormonhaltige arzneimittel | |
ES8707733A1 (es) | Un procedimiento para la preparacion de triazolobenzodiazepinas | |
FI972434A0 (fi) | Lamotrigiiniä sisältävä farmaseuttinen koostumus | |
HU9202044D0 (en) | Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents | |
GR3024611T3 (en) | 8-ENE-19, 11 beta-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM | |
IL113365A (en) | 5-Heterocyclo-1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them | |
DK0701449T3 (da) | Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac | |
MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
MX9708557A (es) | Nuevo uso farmacologico de los antagonistas del receptor aii. | |
MX9301546A (es) | Preparado farmaceutico que contiene un canal activador de potasio y un receptor antagonista de la angiotensina ii y proceso para la fabricacion de tal preparado | |
TW252979B (es) | ||
TW261605B (es) | ||
TW371661B (en) | Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides | |
TW344650B (en) | Fungicidal compositions and the process for the preparation thereof | |
ES2137665T3 (es) | Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos. | |
ES2027507A6 (es) | Procedimiento de preparacion de derivados selenofenicos. | |
MX9710002A (es) | Nuevo uso medico. |